Fig. S5
Quantification and controls for nlcam over-expression and morpholino
A: Quantification of the frequency of phenotypes observed upon injection of nlcam mRNA at 10ng/μl. Results show one representative experiment (ie embryos from a single batch injected at the same time). “Severe phenotype” denotes failed or disrupted gastrulation, or severe convergent-extension and/or neural tube defects.
B: Quantification of the frequency of phenotypes observed upon injection of nlcam ATG morpholino at either 0.2mM or 0.4mM (as indicated). As above, results show one representative experiment.
C, D: nlcam ATG morpholino represses GFP expression from a construct in which the target sequence is placed upstream of the GFP coding sequence. In embryos co-injected with this construct plus the morpholino, no GFP expression can be seen.
E, F: A second morpholino, targeted against the e3, i4 splice junction, phenocopes the ATG morpholino.
Reprinted from Developmental Biology, 339(1), Brown, K.E., Keller, P.J., Ramialison, M., Rembold, M., Stelzer, E.H., Loosli, F., and Wittbrodt, J., Nlcam modulates midline convergence during anterior neural plate morphogenesis, 14-25, Copyright (2010) with permission from Elsevier. Full text @ Dev. Biol.